Action A000520 SAMIL PHARMACEUTICAL CO.,LTD
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Samil Pharmaceutical Co.,Ltd

Actions

A000520

KR7000520007

Cours en clôture Korea S.E.
Autres places de cotation
 00:00:00 04/07/2024 		Varia. 5j. Varia. 1 janv.
7 980 KRW -0,99 % Graphique intraday de Samil Pharmaceutical Co.,Ltd -5,34 % +19,10 %
14/05 Samil Pharmaceutical Co.,Ltd présente ses résultats pour le premier trimestre terminé le 31 mars 2024 CI
14/03 Samil Pharmaceutical Co.,Ltd publie ses résultats pour l'exercice clos le 31 décembre 2023 CI

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Samil Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024
Samil Pharmaceutical Co.,Ltd Reports Earnings Results for the Full Year Ended December 31, 2023
Samil Pharmaceutical Co.,Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
Samil Pharmaceutical Co.,Ltd Reports Earnings Results for the First Quarter Ended March 31, 2023
Samil Pharmaceutical Co.,Ltd announced that it has received KRW 12 billion in funding
Samil Pharmaceutical Co.,Ltd announced that it expects to receive KRW 12 billion in funding
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on November 30, 2021.
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on November 30, 2021.
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on November 30, 2021.
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on November 30, 2021.
Samil Pharmaceutical Co.,Ltd's Equity Buyback announced on November 30, 2021, has expired with 125,939 shares, representing 0.99% for KRW 997.71 million.
Samil Pharmaceutical Co.,Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on October 5, 2021.
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on October 5, 2021.
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on October 5, 2021.
Tranche Update on Samil Pharmaceutical Co.,Ltd's Equity Buyback Plan announced on October 5, 2021.
Samil Pharmaceutical Co.,Ltd's Equity Buyback announced on October 5, 2021, has expired with 119,560 shares, representing 0.94% for KRW 996.5 million.
Samil Pharmaceutical Co.,Ltd Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
Samil Pharmaceutical Co.,Ltd announced that it has received KRW 4 billion in funding
Samil Pharmaceutical Co.,Ltd announced that it has received KRW 5 billion in funding
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action A000520
  4. Actualités Samil Pharmaceutical Co.,Ltd
  5. Autres langues